Search

everythinglearnresearchcommunity

for

Search:↓

The article suggests renaming Polycystic Ovarian Syndrome (PCOS) to "Hyperandrogenic Persistent Ovulatory Dysfunction Syndrome" (HA-PODS) for accuracy and consistency, but no final decision was made.

Hair follicles could be used to noninvasively monitor our body's internal clock and help identify risks for related diseases.

Eriocitrin and silymarin might be effective for hair loss treatment and need more research.

Testosterone's effects on COVID-19 are unclear and need more research.

Vitamin D might help regulate insulin in the body, but taking Vitamin D supplements doesn't clearly prevent or improve type 2 diabetes. More research is needed.

Finger length ratios might predict risk for skin condition in males.

17α-estradiol is a safe estrogen that might protect the brain and doesn't cause feminization, needing more research for treating brain diseases.

The document concludes that sexual and psychiatric side effects from 5-alpha-reductase inhibitors are reported, but more high-quality research is needed to understand how often they occur.

The document is a detailed medical reference on skin and genetic disorders.

Minoxidil may work for hair loss by reducing androgen sensitivity and altering hormone-related enzymes.

The document concludes that using LC-MS/MS for measuring androgens is more accurate than older methods, but it needs careful validation and standardized references to be most effective.

Finasteride effectively treats hair loss and enlarged prostate in men, with mild side effects.

Hair analysis can show nutritional status and environmental exposure, with phosphorus being very stable in hair and differences found based on gender and conditions like depression and autism.

Hair ages due to genetics and environmental factors, leading to graying and thinning, with treatments available for some conditions.

Polycystic Ovary Syndrome (PCOS) symptoms vary globally, with bloating, high cholesterol, and glucose levels being common; the current diagnostic criteria may need refining.

Women with PCOS are at high risk of glucose metabolism issues and heart diseases, especially if overweight, highlighting the need for early intervention.

Women with PCOS have higher levels of certain androgens, which are good at predicting excess hair growth.

Testosterone treatment in trans men increases body and facial hair and may lead to hair loss over time, but severe skin issues are rare.

5-alpha reductase inhibitors can cause sexual side effects like erectile dysfunction and reduced sexual desire, sometimes lasting after stopping the drug.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

Finasteride doesn't affect oral testosterone undecanoate, and high DHT levels may cause acne, prostate issues, and hair loss.

Herbal hair gel with fenugreek seed extract was found to increase hair growth.

Women with PCOS are at higher risk for gum disease, and managing shared risk factors can help both conditions.

Ayurvedic treatment, exercise, and a healthy diet can effectively manage PCOD symptoms.

Skin symptoms are important for diagnosing infections in children.

Some patients taking finasteride or dutasteride may have ongoing sexual problems and depression even after stopping the medication.

Finasteride for hair loss may cause persistent sexual symptoms, depression, anxiety, and lower quality of life.

DHEA did not improve sexual function, well-being, or menopausal symptoms in postmenopausal women with low libido but caused side effects like acne and increased facial hair.

Behçet's Disease may be caused by genetic and environmental factors leading to abnormal immune responses, and stress management and new treatments could improve patient outcomes.

Finasteride doesn't affect hormone levels in normal men.